FDA's July update lists 211 newly cleared AI-enabled medical devices, with radiology comprising the majority.
Key Details
- 1211 AI-enabled medical devices cleared by the FDA since September 2024.
- 2About 81% of these updated clearances are radiology software products.
- 3QIH (automated radiological image processing) leads with 58 new clearances.
- 4New de novo authorization for Clairity's Allix5 software which analyzes breast cancer risk from images.
- 5Eight image analyzer products for mammography, ultrasound, and radiographs were reclassified from class III to class II in 2024.
- 6FDA plans to tag devices using foundation models, including LLMs and multimodal AI.
Why It Matters
Radiology continues to be at the forefront of FDA-cleared AI innovation, highlighting the field's rapid adoption of advanced technologies. Monitoring regulatory trends, device reclassifications, and transparency measures is critical for radiology and imaging AI professionals.
Source
AuntMinnie
Related News
•AI in Healthcare
Landmark AI Mammography Trial and CMS Launches AI Prior Authorization Pilot
New large randomized trial to test AI in mammography screening, while CMS launches a multi-state pilot using AI for Medicare prior authorizations.
•AuntMinnie
AI Device Manufacturers Paid $39.7M for Radiology Between 2017–2023
AI/ML-enabled medical device firms paid $39.7 million for radiology devices from 2017–2023, raising transparency concerns.
•AI in Healthcare
AI’s Expanding Role in Healthcare: Insights from Industry Leaders and Innovators
Leading tech companies and healthcare experts discuss AI’s potential to transform clinical, operational, and diagnostic workflows across healthcare, including radiology.